Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solriamfetol for Excessive Sleepiness in Shift Work Disorder
NCT04788953Phase 4Terminated
- Start
- Jul 2021
- Primary completion
- Apr 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of solriamfetol in shift work sleep disorder (SWSD). Started Jul 2021; status: terminated.
02
Drugs
solriamfetol
03
Conditions
shift work sleep disorder (SWSD)
Beyond the preview
Go deeper on NCT04788953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04788953.